Insulin activates EGFR by stimulating its interaction with IGF-1R in low-EGFR-expressing TNBC cells

키워드

참고문헌 (26)

1. Rakha EA, "Metastatic triple-negative breast cancer", Clin Oncol, 23, pp.587~600 (2011)
2. Nielsen TO, "Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma", Clin Cancer Res, 10, pp.5367~5374 (2004)
3. McClelland RA, "Enhanced epidermal growth factor receptor signaling in MCF7 breast cancer cells after long-term culture in the presence of the pure antiestrogen ICI 182, 780(Faslodex)", Endocrinology, 142, pp.2776~2788 (2001)
4. Knowlden JM, "Elevated levels of epidermal growth factor receptor", c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells, 2003, pp.144, 1032~1044
5. Jin Q, "Cross-talk between the ErbB", HER family and the type I insulin-like growth factor receptor signaling pathway in breast cancer, 2008, pp.13, 485~498
6. Jones HE, "Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells", Endocr Relat Cancer, 11, pp.793~814 (2004)
7. Chakravarti A, "Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling", Cancer Res, 62, pp.200~207 (2002)
8. Liu B, "Fibroblast growth factor and insulin-like growth factor differentially modulate the apoptosis and G1 arrest induced by anti-epidermal growth factor receptor monoclonal antibody", Oncogene, 20, pp.1913~1922 (2001)
9. Morgillo F, "Heterodimerization of insulin-like growth factor receptor", epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinib, 2006, pp.66, 10100~10111
10. Sachdev D, "Inhibitors of insulin-like growth factor signaling: a therapeutic approach for breast cancer", J Mammary Gland Biol Neoplasia, 11, pp.27~39 (2006)
11. Yarden Y, "Untangling the ErbB signalling network", Nat Rev Mol Cell Biol, 2, pp.127~137 (2001)
12. Lehmann BD, "Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies", J Clin Invest, 121, pp.2750~2767 (2011)
13. Yamasaki F, "Sensitivity of breast cancer cells to erlotinib depends on cyclin-dependent kinase 2 activity", Mol Cancer Ther, 6, pp.2168~2177 (2007)
14. DiGiovanni J, "Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice", Proc Natl Acad Sci U S A, 97, pp.3455~3460 (2000)
15. Carboni JM, "Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor", Cancer Res, 65, pp.3781~3787 (2005)
16. Lee CT, "Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate antitumor effects on lung cancer", Cancer Gene Ther, 10, pp.57~63 (2003)
17. Gallagher EJ, "The proliferating role of insulin and insulin-like growth factors in cancer", Trends Endocrinol Metab, 21, pp.610~618 (2010)
18. Pollak M, "Targeting insulin and insulin-like growth factor signalling in oncology", Curr Opin Pharmacol, 8, pp.384~392 (2008)
19. Pollak M, "Insulin and insulin-like growth factor signalling in neoplasia", Nat Rev Cancer, 8, pp.915~928 (2008)
20. Fierz Y, "Insulin-sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progression", Diabetes, 59, pp.686~693 (2010)
21. Carboni JM, "BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R", IR, 2009, pp.8, 3341~3349
22. Haluska P, "HER receptor signaling confers resistance to the insulin-like growth factor-I receptor inhibitor, BMS-536924", Mol Cancer Ther, 7, pp.2589~2598 (2008)
23. Fan QW, "A dual phosphoinositide-3-kinase alpha", mTOR inhibitor cooperates with blockade of epidermal growth factor receptor in PTEN-mutant glioma, 2007, pp.67, 7960~7965
24. Jones RB, "A quantitative protein interaction network for the ErbB receptors using protein microarrays", Nature, 439, pp.168~174 (2006)
25. Riedemann J, "The EGF receptor interacts with the type 1 IGF receptor and regulates its stability", Biochem Biophys Res Commun, 355, pp.707~714 (2007)
26. Ryu JH, "In vivo fluorescence imaging for cancer diagnosis using receptor-targeted epidermal growth factor-based nanoprobe", Biomaterials, 34, pp.9149~9159 (2013)

관련 논문AI추천